Bone as a regulator and responder to acute inflammation throughout life
骨骼作为一生中急性炎症的调节器和反应器
基本信息
- 批准号:10254401
- 负责人:
- 金额:$ 55.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-15 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAcute-Phase ReactionAdultAgingAgreementAmino AcidsAnti-Inflammatory AgentsBacterial InfectionsBloodBlood CirculationBone MarrowBone TissueBrainCell WallCellsCellular StructuresCharacteristicsDataDendritic CellsDesire for foodDiseaseEndocrineEndotoxemiaEscherichia coli InfectionsEventExhibitsGangliaGanglionic BlockersGlutamate TransporterGlutamatesGoalsGram-Negative BacteriaHormonesHourImmuneImmune responseImpairmentIn VitroInflammationInflammatoryInflammatory ResponseInnate Immune ResponseKainic Acid ReceptorsLCN2 geneLactate DehydrogenaseLifeLipopolysaccharidesMediatingMediationMetabolicModelingMusN-Methyl-D-Aspartate ReceptorsNatural ImmunityNeuronsNeuropeptidesNeurotransmittersOrganOsteoblastsOsteocalcinPhenotypePlayPredispositionProteinsRoleSavingsSense OrgansSepsisSerumSignal PathwaySignal TransductionStimulusStressTimeTissuesaging populationbasebonecytokinehuman old age (65+)in vivoindexinginhibitor/antagonistinterestmacrophagemonocytemortalityneurotransmissionnovelpreventreceptorresponsesensorstressorsystemic inflammatory responsetransmission processyoung adult
项目摘要
Project Summary – Project #2
We have recently shown that osteoblast-derived LCN2 suppresses appetite. At the same time, LCN2 is known
as an acute phase response protein that following bacterial infections is highly increased in the serum. Since
Lcn2 is primarily expressed by osteoblasts, we explored, whether osteoblast-derived LCN2 is an early sensor
and regulator of inflammation. This response is of particular interest within the context of the aging population
in which immune system responses are weakened and inflammation more common. Our preliminary data,
using as a model of inflammatory response lipopolysaccharides (LPS) administration in mice, indicate that
following an inflammatory stimulus, brain-derived signals rapidly stimulate osteoblasts to secrete LCN2 in the
circulation. Release of LCN2 from osteoblasts is stimulated by glutamate and is regulated neuronally. This
response is compromised with aging and may contribute to inflammation susceptibility with old age. Circulating
LCN2 acts on key immune cells of the blood and other tissues and modulates their phenotype and subsequent
function to contain endotoxemia, organ damage, and mortality. Based on these and other preliminary data, we
hypothesize that bone is an acute inflammation-sensing organ that mounts lifesaving anti-
inflammatory responses through LCN2 secretion by osteoblasts. To examine this hypothesis we will
establish that osteoblast-derived LCN2 is required for mounting innate immune response using young and old
adult mice with osteoblast-specific deletion of Lcn2 and models of LPS and bacterial infection and sepsis;
inactivate the Grik5 receptor specifically in osteoblasts and examine whether it prevents LCN2 release in the
serum after inflammation and exacerbates disease in young adult and in aging mice; establish the signaling
pathway that originates in the brain and signals the release of LCN2 by osteoblasts in young adult and in aging
mice. These studies will define a new function of bone as an acute inflammatory stressor and responder and
delineate how the brain orchestrates a rapid response through bone and LCN2 to regulate systemic
inflammation with aging.
项目摘要 – 项目 #2
我们最近发现成骨细胞衍生的 LCN2 可以抑制食欲,同时 LCN2 也是已知的。
作为一种急性期反应蛋白,细菌感染后血清中的浓度大大增加。
Lcn2主要由成骨细胞表达,我们探讨了成骨细胞衍生的LCN2是否是早期传感器
这种反应在人口老龄化的背景下特别令人感兴趣。
我们的初步数据显示,免疫系统反应减弱,炎症更加常见。
使用脂多糖(LPS)给药小鼠作为炎症反应模型,表明
炎症刺激后,脑源性信号迅速刺激成骨细胞分泌 LCN2
成骨细胞释放 LCN2 受到谷氨酸的刺激并受到神经元的调节。
随着年龄的增长,反应会受到损害,并可能导致老年时的炎症易感性。
LCN2 作用于血液和其他组织的关键免疫细胞并调节其表型和后续
控制内毒素血症、器官损伤和死亡率的功能 基于这些和其他初步数据,我们
得出结论,骨头是一种急性炎症感应器官,可以发挥救生抗病毒作用
通过成骨细胞分泌 LCN2 产生炎症反应 为了验证这一假设,我们将进行验证。
确定成骨细胞衍生的 LCN2 是年轻人和老年人发起先天免疫反应所必需的
成骨细胞特异性缺失 Lcn2 的成年小鼠以及 LPS、细菌感染和败血症模型;
使成骨细胞中的 Grik5 受体失活,并检查它是否阻止成骨细胞中 LCN2 的释放
年轻小鼠和衰老小鼠炎症后和病情恶化后的血清建立信号传导;
起源于大脑的信号通路,在年轻人和衰老过程中通过成骨细胞释放 LCN2
这些研究将定义骨作为急性炎症应激源和反应源的新功能。
描绘大脑如何通过骨骼和 LCN2 协调快速反应来调节全身
伴随着衰老的炎症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STAVROULA KOUSTENI其他文献
STAVROULA KOUSTENI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STAVROULA KOUSTENI', 18)}}的其他基金
Molecular Mechanisms of MDS pathogenesis with aging
MDS随衰老发病的分子机制
- 批准号:
10737177 - 财政年份:2023
- 资助金额:
$ 55.13万 - 项目类别:
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development
ATRA 抑制成骨细胞诱导的 MDS 发展的细胞和分子机制
- 批准号:
10348733 - 财政年份:2021
- 资助金额:
$ 55.13万 - 项目类别:
Hormones: Molecular Mechanism of Action and Functions
激素:作用和功能的分子机制
- 批准号:
10207070 - 财政年份:2021
- 资助金额:
$ 55.13万 - 项目类别:
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development
ATRA 抑制成骨细胞诱导的 MDS 发展的细胞和分子机制
- 批准号:
10542398 - 财政年份:2021
- 资助金额:
$ 55.13万 - 项目类别:
Bone as a regulator and responder to acute inflammation throughout life
骨骼作为一生中急性炎症的调节器和反应器
- 批准号:
10417243 - 财政年份:2010
- 资助金额:
$ 55.13万 - 项目类别:
Bone as a regulator and responder to acute inflammation throughout life
骨骼作为一生中急性炎症的调节器和反应器
- 批准号:
10632046 - 财政年份:2010
- 资助金额:
$ 55.13万 - 项目类别:
Bone as a regulator and responder to acute inflammation throughout life
骨骼作为一生中急性炎症的调节器和反应器
- 批准号:
10024564 - 财政年份:2010
- 资助金额:
$ 55.13万 - 项目类别:
Sirtuin/FOXO Signaling in the Regulation of Bone Mass
Sirtuin/FOXO 信号在骨量调节中的作用
- 批准号:
7808346 - 财政年份:2009
- 资助金额:
$ 55.13万 - 项目类别:
Sirtuin/FOXO Signaling in the Regulation of Bone Mass
Sirtuin/FOXO 信号在骨量调节中的作用
- 批准号:
8064679 - 财政年份:2008
- 资助金额:
$ 55.13万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia
优化他非诺喹的剂量以根治东南亚间日疟原虫疟疾
- 批准号:
10703688 - 财政年份:2023
- 资助金额:
$ 55.13万 - 项目类别:
Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia
优化他非诺喹的剂量以根治东南亚间日疟原虫疟疾
- 批准号:
10703688 - 财政年份:2023
- 资助金额:
$ 55.13万 - 项目类别:
Decentralized differentially-private methods for dynamic data release and analysis
用于动态数据发布和分析的去中心化差分隐私方法
- 批准号:
10740597 - 财政年份:2023
- 资助金额:
$ 55.13万 - 项目类别:
Anaerobic Manufacturing and Molecular Analytical Process Optimization to Support Clinical Development of Live Biotherapeutic Products
厌氧制造和分子分析过程优化支持活生物治疗产品的临床开发
- 批准号:
10561682 - 财政年份:2022
- 资助金额:
$ 55.13万 - 项目类别: